Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,523 across all filing types
Latest filing 2017-05-09 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
CONNECTED TRANSACTION-ACQUISITION OF THE ENTIRE EQUITY INTEREST IN CSPC DOPHEN CORPORATION
Capital/Financing Update Classification · 95% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding the acquisition of the entire equity interest in CSPC Dophen Corporation. It details the transaction terms, parties involved, consideration, and regulatory implications under the Hong Kong Listing Rules, specifically Chapter 14A concerning connected transactions. The document is structured as a formal announcement with no financial statements or detailed financial analysis beyond summary figures related to the acquisition. It does not contain comprehensive financial data or management discussion typical of annual or interim reports. The content focuses on the transaction details and regulatory compliance, fitting the category of Capital/Financing Update (CAP) which covers updates on company fundraising, financing activities, or capital structure changes such as acquisitions. The document length (8941 characters) and content confirm it is a full announcement rather than a brief notice or a report publication announcement.
2017-05-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/04/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on share capital changes and securities movements rather than financial performance, management commentary, or regulatory certifications. It is a regulatory filing reporting monthly share capital movements, not a full financial report or announcement of a report. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2017-05-04 English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 25 MAY 2017 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
AGM Information Classification · 95% confidence The document is a proxy form for use at the Annual General Meeting (AGM) of CSPC Pharmaceutical Group Limited, scheduled for 25 May 2017. It includes instructions for shareholders to appoint proxies to vote on various resolutions, including receiving the audited financial statements, re-electing directors, approving dividends, and other corporate governance matters. The document is not the AGM presentation or materials themselves but a form enabling shareholders to vote at the AGM. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms. The document length (6625 characters) and content confirm it is not a brief announcement or a full report but a proxy form related to the AGM.
2017-04-19 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and contains detailed agenda items for the AGM of CSPC Pharmaceutical Group Limited, including receiving and considering audited financial statements, re-election of directors, dividend declaration, and approval of share buyback and issuance mandates. It is a notice announcing the meeting and the business to be conducted, not the actual annual report or financial statements themselves. The document length is about 14,353 characters, which is typical for a detailed AGM notice but does not contain the full financial report or detailed financial data. Therefore, it is classified as AGM Information (AGM-R).
2017-04-19 English
PROPOSALS FOR GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES AND MANDATE TO GRANT OPTIONS, RE-ELECTION OF THE RETIRING DIRECTORS, ADOPTION OF NEW ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL
AGM Information Classification · 95% confidence The document is a circular from CSPC Pharmaceutical Group Limited dated April 20, 2017, containing detailed proposals for the upcoming Annual General Meeting (AGM) scheduled for May 25, 2017. It includes proposals for general mandates to buy back shares and issue shares, re-election of retiring directors, adoption of new articles of association, and the notice of the AGM itself. The content includes explanatory statements, details of retiring directors, and changes to articles of association, all typical of materials sent to shareholders ahead of an AGM. The document is not a report of financial results, audit, or earnings, nor is it a transcript or legal proceeding update. It is a comprehensive circular related to the AGM, including the notice and proxy form instructions. Therefore, it fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content confirm it is the meeting materials, not just a brief announcement or proxy solicitation alone.
2017-04-19 English
ANNUAL REPORT 2016
Annual Report Classification · 100% confidence The document contains a detailed table of contents listing sections such as Corporate Information, Financial Highlights, Chairman's Statement, Management Discussion and Analysis, Environmental, Social & Governance Report, Corporate Governance Report, Directors' Report, Independent Auditor's Report, and full Consolidated Financial Statements including Profit or Loss, Financial Position, Changes in Equity, Cash Flows, and Notes. The document is titled 'Annual Report 2016' and includes comprehensive financial data and analysis for the fiscal year 2016. The length of the document is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. The presence of the Independent Auditor's Report within the document does not make it a standalone audit report but part of the full annual report. Therefore, this document fits the definition of an Annual Report (10-K). FY 2016
2017-04-19 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.